Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort descending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort descending Business Functional Area Date Posted
Laboratorijski analitik (m/ž/d) Ljubljana Slovenia Quality Oct 10, 2024
AD, QA, Evaluations and Integrations Cambridge (USA) USA Biomedical Research Pharma Research Quality Oct 25, 2024
Research & Development Quality Specialist Barcelona Gran Vía Spain Development Innovative Medicines Quality Oct 15, 2024
Associate Director, Clinical QA East Hanover USA Development Innovative Medicines Quality Sep 24, 2024
Associate Director Data Ops & Analytics, RDQ Hyderabad (Office) India Development Innovative Medicines Quality Sep 03, 2024
Quality Manager GCP / PV Hyderabad (Office) India Development Innovative Medicines Quality Sep 03, 2024
Global QMS RDQ Senior Specialist Hyderabad (Office) India Development Innovative Medicines Quality Oct 13, 2024
Senior Quality Manager (m/f/d) Schaftenau Austria Development Innovative Medicines Quality Oct 03, 2024
GCP Inspection Project Manager London (The Westworks) United Kingdom Development Innovative Medicines Quality Oct 16, 2024
QC Analyst Ivrea Italy International Innovative Medicines Quality Oct 11, 2024
(Senior) QA Operations Specialist Schaftenau Austria Operations Innovative Medicines Quality Sep 26, 2024
QC Analyst II / Labortechniker (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 07, 2024
AS&T Expert Schaftenau Austria Operations Innovative Medicines Quality Oct 14, 2024
Compliance & Quality System Manager Ivrea Italy Operations Innovative Medicines Quality Oct 17, 2024
QC Analyst II. Basel (Land) Switzerland Operations Innovative Medicines Quality Sep 03, 2024
Senior QC Specialist Kundl Austria Operations Innovative Medicines Quality Sep 09, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Labortechniker / QC Analyst II im Mikrobiologischen Labor (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 23, 2024
AS&T Expert Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
Labortechniker / QC Analyst II (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
AS&T Specialist Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
QC Analyst/ Specialist Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 13, 2024
Quality Assurance Manager - QP/RP Amsterdam Netherlands Operations Innovative Medicines Quality Sep 17, 2024
Analyst Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 20, 2024
QC Site Manager / Responsable CQ - pharmacien adjoint SCL - H/F Saint-Cloud France Operations Innovative Medicines Quality Sep 03, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
AS&T Hub Team Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Sep 03, 2024
Labortechniker / QC Analyst II (m/w/d), Kundl, Tirol Kundl Austria Operations Innovative Medicines Quality Sep 26, 2024
QC Specialist II (m/w/d) Kundl, Tirol Kundl Austria Operations Innovative Medicines Quality Sep 26, 2024
Vodja skupine kontrole kakovosti v QLS Velike Molekule / Vodja laboratorija Bioanalitika (m/f/d), Mengeš Mengeš Slovenia Operations Innovative Medicines Quality Sep 27, 2024
Innovation Manager Hyderabad (Office) India Operations Innovative Medicines Quality Sep 30, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
AS&T Specialist İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Sep 03, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA SF) Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
QC Analyst IV - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Jun 04, 2024
eCompliance Manager Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Expert GMP Auditor Mumbai (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Senior GCP/PV Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Sep 03, 2024
Senior GCP/PV Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Sep 03, 2024
AS&T Expert - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
AS&T Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
QA Compliance Expert – Reg CMC Facilitator Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Analyst - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Associate, QA Officer Operations Sasayama Japan Operations Innovative Medicines Quality Sep 03, 2024
Head of Quality Carlsbad USA Operations Innovative Medicines Quality Sep 03, 2024

Pagination

  • 1
  • 2
  • 3
  • 4
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia